{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:50:35Z","timestamp":1791813035245,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Biomarkers that facilitate earlier diagnosis of posttraumatic infection could improve outcomes by expediting treatment and mitigating complications, including sepsis. We hypothesized that circulating myeloid-derived suppressor cell (MDSC) counts could identify patients with posttraumatic infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN, SETTING, AND PATIENTS:<\/jats:title>\n            <jats:p>We conducted a single-center, prospective observational pilot study of trauma victims who required greater than or equal to 48 hours of mechanical ventilation. Whole blood was collected and tested by flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Samples were analyzed in real-time with an 11-parameter quantitative MDSC assay. Two physician adjudications of infection were performed through a blinded review of medical records. MDSC and other cell counts were compared between subjects with and without posttraumatic infection using non-parametric methods. Data are presented as medians (25th\u201375th percentile). The area under the receiver operating characteristic (ROC) curves were used to assess the accuracy of cell counts for diagnosing infection. Most subjects (<jats:italic toggle=\"yes\">n<\/jats:italic> = 39) were male (79%) with a median age of 48 (interquartile range [IQR] 32\u201365), Injury Severity Score of 29 (IQR 21\u201341), and ICU length of stay of 13 days (IQR 8\u201319). Twenty-one (54%) developed an infection and 11 (28%) of the cohort died. We compared total MDSC (T-MDSC) counts closest to the day of infection diagnosis with the initial T-MDSC counts in subjects without infection. T-MDSC counts were higher in those with infection compared to those without infection (696 [368\u2013974] and 304 [181\u2013404] cells\/\u03bcL, respectively; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Lymphocyte, neutrophil, and CD45+ leukocyte counts were not statistically different between the groups. The area under the ROC curve distinguishing those with infection from those without for T-MDSC was 0.83 (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>MDSC counts determined by quantitative whole blood flow cytometrics can detect posttraumatic infection and may be useful to guide further diagnostic testing in critically ill trauma victims.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001228","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:00:39Z","timestamp":1742324439000},"page":"e1228","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Pilot Study Assessing the Utility of Quantitative Myeloid-Derived Suppressor Cell Measurements in Detecting Posttraumatic Infection"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7453-9429","authenticated-orcid":false,"given":"Grant E.","family":"O\u2019Keefe","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Washington, School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Mirabadi","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Apodaca","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qui","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Harborview Injury Prevention Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"R1-20250318","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20250318","doi-asserted-by":"crossref","first-page":"e2251445","DOI":"10.1001\/jamanetworkopen.2022.51445","article-title":"Defining posttraumatic sepsis for population-level research.","volume":"6","author":"Stern","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R3-20250318","first-page":"115","article-title":"Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study.","volume":"66","author":"Shalhub","year":"2009","journal-title":"J Trauma"},{"key":"R4-20250318","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20250318","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R6-20250318","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R7-20250318","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/CCM.0000000000004451","article-title":"Trends, cost, and mortality from sepsis after trauma in the United States: An evaluation of the national inpatient sample of hospitalizations, 2012-2016.","volume":"48","author":"Eguia","year":"2020","journal-title":"Crit Care Med"},{"key":"R8-20250318","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/SHK.0000000000001795","article-title":"Myeloid-derived suppressor cells (MDSCs) and the immunoinflammatory response to injury (Mini Review).","volume":"56","author":"Sayyadioskoie","year":"2021","journal-title":"Shock"},{"key":"R9-20250318","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40635-022-00431-0","article-title":"High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure.","volume":"10","author":"Schrijver","year":"2022","journal-title":"Intensive Care Med Exp"},{"key":"R10-20250318","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","article-title":"Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis.","volume":"196","author":"Uhel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250318","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s40425-019-0674-1","article-title":"Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.","volume":"7","author":"Apodaca","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"R12-20250318","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"61","author":"von","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R13-20250318","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/TA.0b013e3182349d14","article-title":"Ventilator-associated pneumonia: bacteremia and death after traumatic injury.","volume":"72","author":"O\u2019Keefe","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R14-20250318","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/SLA.0000000000001783","article-title":"Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis\/septic shock.","volume":"265","author":"Mathias","year":"2017","journal-title":"Ann Surg"},{"key":"R15-20250318","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/cells13040314","article-title":"Myeloid-derived suppressor-like cells as a prognostic marker in critically ill patients: Insights from experimental endotoxemia and intensive care patients.","volume":"13","author":"Schrijver","year":"2024","journal-title":"Cells"},{"key":"R16-20250318","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.idc.2023.12.004","article-title":"Management of ventilator-associated pneumonia: Guidelines.","volume":"38","author":"Metersky","year":"2024","journal-title":"Infect Dis Clin North Am"},{"key":"R17-20250318","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s13054-019-2669-1","article-title":"The prognostic value of serum procalcitonin measurements in critically injured patients: A systematic review.","volume":"23","author":"AlRawahi","year":"2019","journal-title":"Crit Care"},{"key":"R18-20250318","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1515\/cclm-2021-1331","article-title":"Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: A systematic review and meta-analysis.","volume":"60","author":"Agnello","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"R19-20250318","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/CCM.0000000000005027","article-title":"Gene expression-based diagnosis of infections in critically ill patients-prospective validation of the sepsismeta score in a longitudinal severe trauma cohort.","volume":"49","author":"Thair","year":"2021","journal-title":"Crit Care Med"},{"key":"R20-20250318","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.201712-2472OC","article-title":"Validation of a host response assay, SeptiCyte LAB, for discriminating sepsis from systemic inflammatory response syndrome in the ICU.","volume":"198","author":"Miller","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20250318","doi-asserted-by":"crossref","first-page":"e0246980","DOI":"10.1371\/journal.pone.0246980","article-title":"Development and validation of a cellular host response test as an early diagnostic for sepsis.","volume":"16","author":"Guillou","year":"2021","journal-title":"PLoS One"},{"key":"R22-20250318","doi-asserted-by":"crossref","first-page":"e0460","DOI":"10.1097\/CCE.0000000000000460","article-title":"Assessment of a cellular host response test as a sepsis diagnostic for those with suspected infection in the emergency department.","volume":"3","author":"O\u2019Neal","year":"2021","journal-title":"Crit Care Explor"},{"key":"R23-20250318","doi-asserted-by":"crossref","first-page":"287ra71","DOI":"10.1126\/scitranslmed.aaa5993","article-title":"A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set.","volume":"7","author":"Sweeney","year":"2015","journal-title":"Sci Transl Med"},{"key":"R24-20250318","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41584-018-0005-9","article-title":"Biomarkers as drug development tools: Discovery, validation, qualification and use.","volume":"14","author":"Kraus","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R25-20250318","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/2213235X113019990005","article-title":"Biomarker discovery and translation in metabolomics.","volume":"1","author":"Nagana Gowda","year":"2013","journal-title":"Curr Metabolomics"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:00:46Z","timestamp":1742324446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001228","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}